Abstract Thyroid hormones T3/T4 participate in the fine tuning of development and performance. ). Moreover, Kcnq1 abundance and current were determined in the thyroid FRTL-5 cell line. Furthermore, mRNA encoding KCNQ1 and the subunits KCNE1-5 were discovered in human thyroid tissue. According to patchclamp TSH (10 mUnits/ml) induced a voltage-gated K + current in FRTL-5 cells, which was inhibited by the Kcnq inhibitor chromanol (10 μM). Despite a tendency of TSH plasma concentrations to be higher in Kcnq1 −/− than in Kcnq1 +/+ mice, the T3 and T4 plasma concentrations were significantly smaller in Kcnq1 −/− than in Kcnq1 +/+ mice. Moreover, body temperature was significantly lower in Kcnq1 −/− than in Kcnq1 +/+ mice. In conclusion, Kcnq1 is required for proper function of thyroid glands.
Introduction
The pore-forming K + channel α-subunit KCNQ1 (KvLQT1) is expressed in a wide variety of tissues including the heart [2, 30] , skeletal muscle [10] , stria vascularis [42] , the renal proximal tubule [39] , gastric parietal cells [7, 11, 14] , intestine [7, 14, 26, 33, 35, 39] , and liver [8, 20, 21] .
KCNQ1 is important for a variety of crucial functions including cardiac rhythm [2, 25, 30] , hearing [4, 23] , gastric acid secretion [23, 32] , as well as intestinal and renal transport [40] . Lack of KCNQ1 has been shown to enhance insulin sensitivity [3] and KCNQ1 polymorphisms were associated with diabetes [38, 43] .
In epithelia, KCNQ1 contributes to the maintenance of cell membrane potential, which is an important driving force for electrogenic transport [39] . In thyroid glands, an electrical driving force is required for proper function of the Na + -coupled iodide transporter NIS [5] . KCNQ1 further participates in the regulation of cell volume [1, 12, 20, 21, 41] and cell proliferation [16, 18, 24, 29, 31, 36, 37] . Cell proliferation plays a critical role in the regulation of thyroid follicular mass [9] . The thyroid-stimulating hormone (TSH) stimulates cell proliferation and thus increases the thyroid mass [9] . The increased number of T3/T4-secreting cells thus augments the release of the hormones.
The present study was performed to elucidate whether Kcnq1 is expressed in thyroid glands and whether the channel participates in the regulation of thyroid function. During the course of this study, Kcnq1 has indeed been indirectly implicated in thyroid function [28] . In that study, evidence was presented that lack of Kcne2 leads to hypothyroidism and it was suggested that this phenotype was likely due to loss of potassium channels formed by Kcne2/Kcnq1 heterodimers. Our results indeed demonstrate that Kcnq1 is expressed in the thyroid and that Kcnq1-deficient mice suffer from mild hypothyroidism.
Methods
The mice were bred in the animal facilities of the University of Tübingen and Hannover Medical School. All animal experiments were conducted according to the German law for the welfare of animals and were approved by local authorities.
Experiments were performed in mice deficient in Kcnq1 (Kcnq1 −/− ) and their wild-type littermates (Kcnq1 +/+ ) generated as previously described [4] . For the study, 4-10-month-old Kcnq1 knockout (Kcnq1 −/− ; 2-8 males, 2-7 females) and their wild-type littermates (Kcnq1 +/+ ; 3-8 males, 3-9 females) were selected (TSH levels were in addition measured in 3-week-old mice). Prior to the experiment, the age-and sex-matched mice were fed with control diet (1310/1314, Altromin, Lage, Germany) and were allowed free access to tap water.
To obtain blood specimens, animals were lightly anesthetized with diethylether (Roth, Karlsruhe, Germany) and about 200 μl of blood were withdrawn into heparinized capillaries by puncturing the retro-orbital plexus. Plasma concentrations of free triiodothyronine (fT3), free thyroxine (fT4), and thyroid-stimulating hormone (TSH) were measured using ELISA-kits (Alpha Diagnostics Intl. Inc, San Antonio, Texas, USA, Shibayagi Co., Ltd., Ishihara, Shibukawa, Gunma Pref., Japan). Body temperature was determined utilizing a thermosensor inserted through the anus into sigmoidal colon.
The Kcnq1 transcript levels in mouse thyroid gland and in FRTL-5 cells as well as the KCNQ1 and KCNE1-5 transcript levels in human thyroid gland, colon, stomach, and heart (Stratagene-Agilent Technology, Waldbronn, Germany) were measured by Real-Time reverse transcriptionpolymerase chain reaction (RT-PCR). To this end total RNA was extracted from FRTL-5 cells and mouse thyroid tissue in TriFast (Peqlab, Erlangen, Germany) according to the manufacturer's instructions. Reverse transcription of total RNA (Stratagene, La Jolla, CA, USA) was performed using random hexamers (Roche Diagnostics, Penzberg, Germany) and SuperScriptII reverse transcriptase (Invitrogen, Carlsbad, CA, USA). PCR amplification of the respective genes were set up in a total volume of 20 μl using 40 ng of cDNA, 500 nM forward and reverse primer and 2× iTaq Fast SYBR Green (Bio-Rad, Hercules, CA, USA) according to the manufacturer's protocol. Cycling conditions were performed as follows: initial denaturation at 95 C for 2 min, followed by 40 cycles of 95°C for 15 s, 55°C for 15 s and 68°C for 20 s. The primers used for amplification are listed in Table 1 . Specificity of PCR products was confirmed by analysis of a melting curve. Real-time PCR amplifications were performed on a CFX96 cycler (Bio-Rad, München, Germany) and all experiments were done in doublets. Amplification of the housekeeping gene Tbp was performed to standardize the amount of sample RNA. Relative quantification of gene expression was performed using the ΔΔct method as described earlier [27] . For immunohistochemistry, thyroid glands were fixed with 4% paraformaldehyde, thereafter incubated in 30% sucrose overnight and frozen in Tissue Tek (Polyscience). Then, 12-μm cryosections were prepared. For immunhistochemistry cryosections were air-dried, treated with a fixation solution (4% PFA/PBS, 0.2% Igepal, 0.1% Nadeoxycholate) for 5 min and then washed with PBS. Thereafter, the slides were incubated for 30 min at room temperature in blocking solution (3% NGS, 2% BSA, 0.5% Igepal) and then incubated overnight at 4°C with the primary antibodies diluted in carrier solution (2% BSA, 0.5% Igepal). On the next day, the slides were washed with PBS followed by another incubation step with blocking solution for 15 min at room temperature. Then, the second antibody diluted in carrier solution was added and the slides were incubated for 1 h at room temperature followed by washing with PBS. Finally, the sections were covered with mounting medium (ProLong® Gold Antifade Reagent, Invitrogen) and stored at 4°C in the dark until analysis. A primary antibody directed against Kcnq1 from Abcam (1:1000) was used. Secondary antibodies were Alexa Fluor 488 goat α-rabbit (1:2,000), Draq 5 (1:1,000; Biostatus limited) for nuclear staining, and rhodamine phalloidin (1:1,000; Invitrogen) for actin labeling.
For cell surface biotinylation of FRTL-5 cells, the cells were rinsed twice with ice-cold PBS buffer. Cells were then incubated for 30 min at 4°C in 0.5 mg/ml Sulfo-NHS-LCBiotin (Pierce, Rockford, IL, USA) diluted in ice-cold PBS buffer. After washing twice with ice-cold PBS supplemented with 0.1% BSA (w/v), the cells were dissolved in lysis buffer containing 20 mM Tris (pH 7.4), 5 mM MgCl 2 , 5 mM Na 2 HPO 4 , 1 mM EDTA (pH 8.0), 80 mM sucrose, 1 mM PMSF. Then the cells were rotated for 1 h at 4°C. Thereafter 600 μg of extracted protein was incubated overnight at 4°C with 50 μl neutravidin beads (Pierce). The next day the proteins with the beads were centrifugated at 13,000 rpm at 4°C for 2 min and the supernatant was removed. Then, to wash the beads 500 μl of buffer (1% Triton X100, 0.1 M NaCl, 0,02 M Tris pH 7,4) supplemented with complete protease inhibitor (Roche, Basel, Switzerland) was added and thereafter another centrifugation step at 13,000 rpm at 4°C for 2 min was accomplished. This washing step was recapitulated for four times. Thereafter protein was eluted from the beads by incubation with 20 μl dH 2 O and 5 μl 4× protein loading buffer (Carl Roth, Karlsruhe, Germany). The biotinylated membrane protein was separated by 10% SDS-PAGE and transferred electrophoretically to a nitrocellulose membrane. After blocking with 5% nonfat dry milk in TBS (pH 7.4)/0.15% Tween 20 for 1 h at room temperature, the blots were incubated with the primary antibody (Abcam, rabbit polyclonal to Kcnq1) at 4°C overnight (1:1,000 in TBS/ 0.15% Tween 20/5% non-fat dry milk). After washing, the first antibody was detected by secondary goat anti-rabbit IgG antibody conjugated with horseradish peroxidase (1:2,000, Cell Signaling) for 1 h at room temperature. Antibody binding was detected via Western blotting detection reagent (GE Healthcare UK limited).
Patch-clamp experiments were performed on FRTL-5 cells 48 h after seeding at room temperature in voltage clamp, fastwhole-cell mode according to Hamill et al. [13] . The cells were continuously superfused through a flow system inserted into the dish. The bath was grounded via a bridge filled with NaCl Ringer solution. Borosilicate glass pipettes (1-3 MOhm tip resistance; GC 150 TF-10, Clark Medical Instruments, Pangbourne, UK) manufactured by a microprocessor-driven DMZ puller (Zeitz, Augsburg, Germany) were used in combination with a MS314 electrical micromanipulator (MW, Märzhäuser, Wetzlar, Germany). The currents were recorded by an EPC-9 amplifier (Heka, Lambrecht, Germany) using Pulse software (Heka) and an ITC-16 Interface (Instrutech, Port Washington, N.Y., USA). Whole-cell currents were elicited by 200 ms square-wave voltage pulses from −100 to +100 mV in 20 mV steps from a holding potential of −40 mV. All voltages were corrected for a liquidjunction potential of 8 mV. The currents were recorded with an acquisition frequency of 10 and 3 kHz low-pass filtered. The cells were superfused with a bath solution containing: 140 mM/l NaCl, 5 mM/l KCl, 1 mM/l MgCl 2 , 2 mM/l CaCl 2 , 20 mM/l glucose, and 10 mM/l HEPES/NaOH, pH 7.4. The patch-clamp pipettes were filled with an internal solution containing: 80 mM/l KCl, 60 mM/l K + -gluconate, 1 mM/l MgCl 2 , 1 mM/l Mg-ATP, 1 mM/l EGTA, 1 mM/l cAMP, 10 mM/l HEPES/KOH, pH 7.2. Where indicated chromanol (10 μM, Tocris Bioscience, Bristol, UK) was added to the bath solution.
Data are provided as arithmetic means±SEM, n represents the number of independent experiments. All data were tested for significance using paired or unpaired Student t test, as applicable. Only results with p<0.05 were considered as statistically significant.
Results
RT-PCR was employed to determine whether Kcnq1 is expressed in thyroid glands and Kcnq1 transcripts could indeed be detected in the thyroid tissue (data not shown). The intrathyroid localization of Kcnq1 was determined by immunohistochemistry via confocal microscopy. As shown in Fig. 1 In addition we also checked the expression of KCNQ1 and all known subunits (KCNE1-5) in the human thyroid via Real-time PCR (Fig. 2) . We compared the relative expression of the investigated mRNAs in the human thyroid to the expression found in human colon, stomach, and heart. Similar as in mouse thyroid gland, KCNQ1 is highly expressed in human thyroid tissue. All five beta subunits (KCNE1-5) were expressed in the thyroid, the highest expression being found for KCNE4.
To investigate the Kcnq1 currents in thyroid cells we used the rat FRTL-5 cells. At first Kcnq1-expression in FRTL-5 cells was checked via Real-Time PCR, Western blot with cell surface biotinylation and immunocytochemistry/immunofluorescence (Fig. 3a, b, and c) . All three applied methods showed a clear expression of Kcnq1 in the cells. The immunostaining confirmed that Kcnq1 is expressed both in intracellular vesicles and in the cell membrane (Fig. 3c) , similar to what was observed in the thyroid follicular cells of the mouse.
Endogenous currents from FRTL-5 cells were measured using patch-clamp recording in the whole-cell configuration (Fig. 4) . In accordance to a previous study [28] , K + -selective currents inhibited by a Kcnq-specific antagonist chromanol were recorded, when FRTL-5 cells were cultured in the presence of high TSH concentrations (10 mUnits/ml). The reversal potential in FRTL-5 cells was about −25 mV under control conditions and the reversal potential of the chromanol-sensitive current fraction was about −49 mV. No chromanol-sensitive currents could be measured when no TSH was added in the culture medium (data not shown).
To determine the functional significance of Kcnq1, the plasma concentrations of T3 and T4 were determined in Kcnq1 −/− mice and their wild-type littermates (Kcnq1 +/+ ). As shown in Fig. 5b and c the plasma concentrations of both, T3 and T4, were indeed significantly lower in
Kcnq1
−/− than in Kcnq1 +/+ mice, confirming that Kcnq1 deficiency leads to hypothyroidism. In theory, the decreased release of thyroid hormones in Kcnq1 −/− mice could have resulted from decreased stimulation of the thyroids by the thyroid-stimulating hormone TSH. The plasma levels of TSH, tended to be higher in Kcnq1 −/− compared to Kcnq1 +/+ mice, a difference, however, not reaching statistical significance (Fig. 5a ). TSH levels in 3-week-old mice again tended to be higher in Kcnq1 −/− mice (4.0± 0.1 μIU/ml, n=6) as compared to Kcnq1 +/+ mice (3.5±0.3 μIU/ml, n=6), a difference again not reaching statistical significance. A key feature of hypothyroidism is decreased metabolic rate with decreased body temperature. As shown in Fig. 5d .
Discussion
The present study reveals that Kcnq1 is expressed in the cell membrane of thyroid follicular cells and plays a significant role in thyroid function. Despite the tendency of increased TSH plasma levels, the plasma concentrations of T3/T4 are lower in Kcnq1 knockout (Kcnq1 −/− ) mice than in their wild-type littermates (Kcnq1
). The hypothyroidism of the Kcnq1 −/− mice results in hypothermia, reflecting a decreased metabolic rate. Signs of hypothyroidism include alopecia, impaired hearing, bradycardia, constipation, weight gain, and weakness [15, 19] . In amphibians, T3/T4 are known to be required for the metamorphosis [6] . The phenotype of Kcnq1 −/− mice includes deafness and movement disorders [4, 23] , defective gastric acid secretion [23, 32] , defective renal and intestinal nutrient and electrolyte transport with arterial hypotension, vitamin B 12 deficiency with anemia [40] , as well as enhanced insulin sensitivity [3] . Hypothyroidism could contribute to several of the disorders encountered in Kcnq1 −/− mice. It is noteworthy in this respect that the coincidence of hypothyroidism and torsade de points has been reported [34] . However, as Kcnq1 is expressed in the respective tissues the phenotype of the Kcnq1 −/− mice is presumably in large part secondary to the lack of Kcnq1 in the affected organs rather than the result of the moderate hypothyroidism.
In the course of this study the expression of Kcnq1 has been observed in thyroid glands and shown to form, together with Kcne2, a heteromeric K + channel complex maintaining iodide uptake [28] . Kcne2 deficient (Kcne2 −/− ) offspring of Kcne2 −/− dams developed impaired iodide uptake and hypothyroidism, dwarfism, alopecia, and goiter [28] . The phenotype of the Kcne2 −/− offspring was in large part due to impaired maternal milk ejection of the Kcne2 −/− dams and was alleviated or lacking in Kcne2 −/− mice from heterozygous Kcne2 +/− dams [28] . Our animals have been generated by heterozygous breeding explaining the lack of dwarfism and alopecia despite a similar impairment of T3/T4 release. Nevertheless, both mice have the hypothyroidism in common thus highlighting the importance of the Kcne2/Kcnq1 complex for proper thyroid function.
Kcne2 and Kcnq1 may influence thyroid function in two ways. On the one hand, the K + channel presumably participates in the maintenance of the cell membrane potential and thus the electrical driving force for Na + -coupled iodide transporter NIS [5] . Lack of Kcne2/Kcnq1 may thus impair T3, T4 formation by compromising iodide uptake into the thyroid, what has indeed been shown in Kcne2 −/− mice [28] .
On the other hand, Kcnq1 may participate in the machinery of cell proliferation [16, 18, 24, 29, 31, 36, 37] , which is critically dependent on K + channel activity [17, 22] . Impaired cell proliferation would be expected to reduce thyroid mass. In contrast to the goiter observed in Kcne2 −/− offspring from Kcne2 −/− dams, the size of the thyroids is not appreciably increased in Kcnq1 −/− mice (not shown). Accordingly, the goiter of Kcne2 −/− offspring from Kcne2 −/− dams may have been due to decreased availability of maternal iodine with subsequent stimulation of thyroid growth by TSH. The lack of increase of thyroid mass in Kcnq1 −/− mice despite the similarly increased TSH levels could indicate that Kcnq1 does not only participate in the maintenance of the driving force for NIS (Slc5a5) but similarly participates in the regulation of cell proliferation. It should be kept in mind that for this latter function, Kcnq1 could in theory form heteromeric complexes with subunits other than Kcne2. The role of additional partners of KCNQ1 needs to be addressed in future studies.
In conclusion, the present study discloses a critical role of Kcnq1 in thyroid growth and function. The hypothyroidism may add to the phenotypic alterations of organ function in Kcnq1-deficient mice.
